Safety of intracameral injection of gatifloxacin, levofloxacin on corneal endothelial structure and viability.

PURPOSE To investigate the safety of intracameral injection of gatifloxacin, levofloxacin in a rabbit model as prophylaxis against endophthalmitis. METHODS Twenty-four eyes of New Zealand white rabbits were randomly divided into 3 treatment groups: levofloxacin, gatifloxacin, and balanced salt solution (BSS) control groups. After 100 microL of each was injected into the anterior chamber, endothelial toxicity was evaluated by measuring the central corneal thicknesses and the clinical toxicity scores using a slit-lamp at post-procedure days 3 and 7. The percent of dead cells was determined by vital staining with alizarin red and trypan blue at 7 days after injection. Finally, in each group, scanning electron microscopy (SEM) and transmission electron microscopy (TEM) were performed for the evaluation of structural integrity. RESULTS The toxicity scores were increased at post-procedure days 3 and 7, but the difference among the groups was not statistically significant (P = 0.661, 0.216, respectively). With regard to baseline corneal thickness, only the levofloxacin group exhibited a significant increase from baseline (P = 0.028), whereas the other treatment groups showed no difference from baseline (P = 0.128 in gatifloxacin, 0.161 in BSS group). The mean corneal endothelial damage was 0.81 +/- 0.31% in the levofloxacin group, 0.56 +/- 0.47% in the gatifloxacin group, and 0.53 +/- 0.52% in the BSS group, with no statistically significant difference noted among the groups (P = 0.582). SEM revealed a well-preserved hexagonal endothelial cell mosaic and normal microvilli on the endothelial cell surface in the gatifloxacin and control groups. However, the levofloxacin group showed slightly disintegrated cellular borders. TEM revealed that each group maintained normal intracellular organization, whereas the levofloxacin group exhibited slightly flat cell configuration with irregular folds on the apical cell surface. CONCLUSIONS Intracameral injection of gatifloxacin and levofloxacin was nontoxic in terms of clinical toxicity score, corneal thickness, and viability. However, there were changes on electron microscopy in the levofloxacin group, which may indicate microstructural damage to corneal endothelial cells.

[1]  T. Liesegang Intracameral antibiotics: questions for the United States based on prospective studies. , 2008, Journal of cataract and refractive surgery.

[2]  T. O'brien,et al.  Perspectives on antibiotics for postoperative endophthalmitis prophylaxis: Potential role of moxifloxacin , 2007, Journal of cataract and refractive surgery.

[3]  S. Masket,et al.  Prophylaxis of postoperative endophthalmitis after cataract surgery: Results of the 2007 ASCRS member survey , 2007, Journal of cataract and refractive surgery.

[4]  A. M. Thompson Ocular toxicity of fluoroquinolones , 2007, Clinical & experimental ophthalmology.

[5]  U. Stenevi,et al.  Endophthalmitis after cataract surgery: a nationwide prospective study evaluating incidence in relation to incision type and location. , 2007, Ophthalmology.

[6]  V. Caparas,et al.  Safety of prophylactic intracameral moxifloxacin 0.5% ophthalmic solution in cataract surgery patients , 2007, Journal of cataract and refractive surgery.

[7]  Daniel G Dawson,et al.  Toxic anterior segment syndrome. , 2006, Journal of cataract and refractive surgery.

[8]  W. Mieler,et al.  Clearance of intravitreal moxifloxacin. , 2006, Investigative ophthalmology & visual science.

[9]  S. Seregard,et al.  Risk factors for endophthalmitis following cataract surgery: a retrospective case-control study. , 2005, The Journal of hospital infection.

[10]  E. Romanowski,et al.  Intracameral Vigamox (moxifloxacin 0.5%) is non-toxic and effective in preventing endophthalmitis in a rabbit model. , 2005, American journal of ophthalmology.

[11]  J. Alió,et al.  Severe anaphylactic reaction after intracameral antibiotic administration during cataract surgery. , 2005, Journal of cataract and refractive surgery.

[12]  D. Hwang Fluoroquinolone resistance in ophthalmology and the potential role for newer ophthalmic fluoroquinolones. , 2004, Survey of ophthalmology.

[13]  R. Tipperman Pharmacologic considerations for cataract surgery , 2004, Current opinion in ophthalmology.

[14]  U. Pleyer,et al.  Retinal toxicity of liposome-incorporated and free ofloxacin after intravitreal injection in rabbit eyes , 2004, International Ophthalmology.

[15]  N. Chin,et al.  Intracameral antibiotic agents for endophthalmitis prophylaxis: A pharmacokinetic model , 2003, Journal of cataract and refractive surgery.

[16]  F. Mah New antibiotics for bacterial infections. , 2003, Ophthalmology clinics of North America.

[17]  W. Green,et al.  Ocular toxicity of intravitreal trovafloxacin in the pigmented rabbit , 2003, Current eye research.

[18]  G. Koranyi,et al.  Prophylactic intracameral cefuroxime: Efficacy in preventing endophthalmitis after cataract surgery , 2002, Journal of cataract and refractive surgery.

[19]  C. Zetterström,et al.  Prophylactic intracameral cefuroxime: Evaluation of safety and kinetics in cataract surgery , 2002, Journal of cataract and refractive surgery.

[20]  H. Edelhauser,et al.  Effect of indocyanine green intraocular stain on human and rabbit corneal endothelial structure and viability: An in vitro study , 2002, Journal of cataract and refractive surgery.

[21]  G. Doern Antimicrobial use and the emergence of antimicrobial resistance with Streptococcus pneumoniae in the United States. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[22]  A. M. Berrocal,et al.  Subconjunctival cephalosporin anaphylaxis. , 2001, Ophthalmic surgery and lasers.

[23]  D. Weinberger,et al.  Cystoid macular edema after cataract surgery with intraocular vancomycin. , 1999, Ophthalmology.

[24]  T. Riordan,et al.  The effect of intracameral, per-operative antibiotics on microbial contamination of anterior chamber aspirates during phacoemulsification , 1998, Eye.

[25]  A. Dublanchet,et al.  Vancomycin prophylaxis and intraocular contamination during cataract surgery , 1997, Journal of cataract and refractive surgery.

[26]  W. Tasman,et al.  Postoperative endophthalmitis in association with diabetes mellitus. , 1994, Ophthalmology.

[27]  S. Stevens,et al.  Intraocular safety of ciprofloxacin. , 1991, Archives of ophthalmology.

[28]  G. Peyman,et al.  Ciprofloxacin and dexamethasone inhibit the proliferation of human retinal pigment epithelial cells in culture. , 1991, Current eye research.

[29]  M. Taylor,et al.  Dual staining of corneal endothelium with trypan blue and alizarin red S: importance of pH for the dye-lake reaction. , 1981, The British journal of ophthalmology.